10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference, scheduled for January 11, 2021, at 7:00 a.m. PT / 10:00 a.m. ET. The company's management will present key information, and interested parties can access a live and archived webcast on their Investors page.

10x Genomics develops integrated solutions for biological research, with products widely adopted by leading research institutions and pharmaceutical companies.

PLEASANTON, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming 39^th Annual J.P. Morgan Virtual Healthcare Conference.

10x Genomics’ management is scheduled to present on Monday, January 11 at 7:00 a.m. Pacific Time / 10:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: investors.10xgenomics.com

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including 97 of the top 100 global research institutions and 19 of the top 20 global pharmaceutical companies, and have been cited in over 2,000 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises more than 950 issued patents and patent applications.

Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.        

Contacts
Investors
investors@10xgenomics.com

Media
media@10xgenomics.com

FAQ

When will 10x Genomics present at the J.P. Morgan Virtual Healthcare Conference?

10x Genomics will present on January 11, 2021, at 7:00 a.m. Pacific Time.

How can I access the 10x Genomics presentation from the conference?

You can access the live and archived webcast on the Investors section of the 10x Genomics website.

What is the focus of 10x Genomics as a company?

10x Genomics specializes in life science technology, offering products for analyzing biological systems.

Which major institutions use 10x Genomics products?

10x Genomics products are used by 97 of the top 100 global research institutions and 19 of the top 20 global pharmaceutical companies.

How many patents does 10x Genomics hold?

10x Genomics has a patent portfolio comprising more than 950 issued patents and patent applications.